Wikipedia:Articles for deletion/NeuBase Therapeutics


 * The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review).  No further edits should be made to this page.

The result was redirect to Dietrich Stephan.  Sandstein  20:58, 20 April 2019 (UTC)

NeuBase Therapeutics

 * – ( View AfD View log  Stats )

No apparent basis for notability. They do not have any actual products to address the diseases mentioned. They merely hope to develop them--according to the sources they might file their first IND in 2020, and it would be a long time before anything actually would be approved. Listing the diseases here in a case like this amounts to promotionalism.  DGG ( talk ) 06:39, 13 April 2019 (UTC)
 * Note: This discussion has been included in the list of Companies-related deletion discussions.  CAPTAIN RAJU (T) 06:54, 13 April 2019 (UTC)
 * Note: This discussion has been included in the list of Pennsylvania-related deletion discussions.  CAPTAIN RAJU (T) 06:54, 13 April 2019 (UTC)


 * Delete - Too soon. Sounds like they're a new company working on some potentially interesting things, but not enough to attract sufficient attention to pass WP:CORPDEPTH. &mdash; Rhododendrites  talk \\ 13:58, 13 April 2019 (UTC)
 * Redirect—Point the name at Dietrich Stephan, the founder of the firm. Any non-trivial info could be added as a subtopic there, and an article spun out when/if warranted. --User:Ceyockey ( talk to me ) 18:38, 13 April 2019 (UTC)
 * Note: This discussion has been included in the list of Technology-related deletion discussions. North America1000 18:51, 13 April 2019 (UTC)


 * The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.